COVID-19 & Influenza A+B Antigen Combo Test Kit (Colloidal Gold)
Manufactured by Nantong Diagnos Biotechnology Co. Ltd., Spain - linkcarebio.com
Device identification number
1354
CE Marking
✓Yes
HSC common list (RAT)
×No
Format
Near POC / POC
Physical Support
Cassette
Target type
Antigen
Targets
nucleocapsid protein
Specimen
Nasal swab, Nasopharyngeal swab, Throat swab
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Assay Type
Immuno-Antigen
Rapid Diagnostic
Yes
Reader Required
No
Method
Immunoassay
Measurement
Qualitative
Time
15 minutes
Detection Principle
Colorimetry
LOD
0.05 %
Accuracy
96 %
Clinical Sensitivity
92.59 %
Type of antigen
nucleoprotein
Notes
Accuracy: 97.60% Influenza. Clinical sensitivity 96.67% Influenza
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements